Inion seals biomaterials R&D (research and development) pact with Cambridge Uni
This article was originally published in Clinica
Executive Summary
Inion, the Anglo-Finnish developer of biodegradable medical implants, is to collaborate with the University of Cambridge's Centre for Medical Materials (CCMM) over the next three years on the development of a new medical materials platform. This next-generation technology will combine Inion's Optima biodegradable polymers with nano-phase bioactive ceramics that are currently being developed by CCMM.